Literature DB >> 16763546

Prevalence of anti-desmoglein-3 antibodies in endemic regions of Fogo selvagem in Brazil.

Julio Hilario-Vargas1, David A Dasher, Ning Li, Valeria Aoki, Gunter Hans-Filho, Vandir dos Santos, Bahjat F Qaqish, Evandro A Rivitti, Luis A Diaz.   

Abstract

Fogo selvagem (FS), the endemic form of pemphigus foliaceus (PF), is an autoimmune blistering disease characterized by autoantibodies against desmoglein 1. The Terena reservation of Limao Verde in Mato Grosso do Sul, Brazil, is a previously identified focus of disease. Autoantibodies against desmoglein 3 (Dsg3) have also been detected in sera from patients with FS. In an effort to further characterize the serological, geographical, and clinical epidemiology of the disease, we sought to determine the prevalence of anti-Dsg3 autoantibodies in sera from normal subjects living outside of and in an endemic area using an ELISA. Anti-Dsg3 antibodies were detected in 53 of 146 normal subjects from Limao Verde (36%), and in eight of 140 normal subjects from surrounding areas (6%). A significant trend was observed in the proportion of positive tests relative to distance from the endemic area (P < 0.001). Our seroepidemiological observations support the concept that the likely environmental trigger of the antibody response in FS is located in this endemic area, and that the population at risk to develop FS may also be at risk to develop an endemic form of pemphigus vulgaris as reported by our co-investigators from Brasilia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763546     DOI: 10.1038/sj.jid.5700388

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

Review 1.  Update on fogo selvagem, an endemic form of pemphigus foliaceus.

Authors:  Valeria Aoki; Evandro A Rivitti; Luis A Diaz
Journal:  J Dermatol       Date:  2015-01       Impact factor: 4.005

2.  An insight into the sialotranscriptome of Simulium nigrimanum, a black fly associated with fogo selvagem in South America.

Authors:  José M C Ribeiro; Jesus G Valenzuela; Van M Pham; Lindsay Kleeman; Kent D Barbian; Amanda J Favreau; Donald P Eaton; Valeria Aoki; Gunter Hans-Filho; Evandro A Rivitti; Luis A Diaz
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

Review 3.  From Insect Bites to a Skin Autoimmune Disease: A Conceivable Pathway to Endemic Pemphigus Foliaceus.

Authors:  Ning Li; Valeria Aoki; Zhi Liu; Phillip Prisayanh; Jesus G Valenzuela; Luis A Diaz
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

4.  A hypothesis concerning a potential involvement of ceramide in apoptosis and acantholysis induced by pemphigus autoantibodies.

Authors:  Wendy B Bollag
Journal:  Dermatol Res Pract       Date:  2010-05-18

Review 5.  Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity.

Authors:  Donna A Culton; Ye Qian; Ning Li; David Rubenstein; Valeria Aoki; Gunter Hans Filhio; Evandro A Rivitti; Luis A Diaz
Journal:  J Autoimmun       Date:  2008-10-05       Impact factor: 7.094

Review 6.  Pemphigus autoimmunity: hypotheses and realities.

Authors:  Sergei A Grando
Journal:  Autoimmunity       Date:  2011-09-23       Impact factor: 2.815

Review 7.  Fogo selvagem: endemic pemphigus foliaceus.

Authors:  Günter Hans-Filho; Valéria Aoki; Nelise Ritter Hans Bittner; Guilherme Canho Bittner
Journal:  An Bras Dermatol       Date:  2018 Sep-Oct       Impact factor: 1.896

8.  Pemphigus vulgaris autoantibody profiling by proteomic technique.

Authors:  Mina Kalantari-Dehaghi; Grant J Anhalt; Michael J Camilleri; Alex I Chernyavsky; Sookhee Chun; Philip L Felgner; Algis Jasinskas; Kristin M Leiferman; Li Liang; Steve Marchenko; Rie Nakajima-Sasaki; Mark R Pittelkow; John J Zone; Sergei A Grando
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

9.  Autoantibodies against desmoglein 2 are not pathogenic in pemphigus.

Authors:  Marcela Calixto Brandão Miguel; Tamiris Amanda Julio; Sebastian Vernal; Natália Aparecida de Paula; Andre Lieber; Ana Maria Roselino
Journal:  An Bras Dermatol       Date:  2022-01-17       Impact factor: 2.113

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.